ConductScience.org, home

Cell line · CVCL_0219

COLO 320DM

Cancer cell line, Homo sapiens. Colon adenocarcinoma. 33 papers.

4 sourcescell-lines-2026-11-14-0.1.0

Download JSON
Cite this record

ConductScience Library. COLO 320DM. Cell lines, record CVCL_0219. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0219

On this page

Cell line

As Cellosaurus gives it.

Name
COLO 320DM
Accession
CVCL_0219
RRID
RRID:CVCL_0219
Synonyms
COLO-320DM, COLO_320DM, COLO-320-DM, COLO #320DM, COLO320/DM, COLO320-DM, COLO320DM, Colo320DM, COLO320 DM, COLO 320 DM, COLO 320 (DM), Colorado 320 Double Minutes
Species
Homo sapiens (Human)
Sex
Female
Age at sampling
55Y
Category
Cancer cell line
Diseases
Colon adenocarcinoma (NCIt C4349)
Derived from
Colon, sigmoid (in situ)
Parent
COLO 320 (CVCL_1989)
Entry created
2012-04-04
Entry updated
2025-04-10

Source Cellosaurus

Problems0

Cellosaurus records no problem for this cell line.

None in this release.

Papers33

4 more articles give this line's RRID in its Methods without naming the line nearby, so they are not listed.

PaperJournalYearHow we knowRetractedSource
Basroparib inhibits YAP-driven cancers by stabilizing angiomotin.Mol Oncol2026Its Methods give the RRID and name the linePubMed
Diverse oncogenes use common mechanisms to drive growth of major forms of human cancer.Sci Adv2025Its Methods give the RRID and name the linePubMed
Selective Depletion of Cancer Cells with Extrachromosomal DNA via Lentiviral Infection.Cancer Res Commun2025Its Methods give the RRID and name the linePubMed
Extrachromosomal DNA-Driven Oncogene Dosage Heterogeneity Promotes Rapid Adaptation to Therapy in MYCN-Amplified Cancers.Cancer Discov2025Its Methods give the RRID and name the linePubMed
The E3 Ligase NEDD4L Prevents Colorectal Cancer Liver Metastasis via Degradation of PRMT5 to Inhibit the AKT/mTOR Signaling Pathway.Adv Sci (Weinh)2025Its Methods give the RRID and name the linePubMed
Reduced chemokine C-C motif ligand 1 expression may negatively regulate colorectal cancer progression at liver metastatic sites.J Cell Mol Med2024Its Methods give the RRID and name the linePubMed
A Novel Class of Ribosome Modulating Agents Exploits Cancer Ribosome Heterogeneity to Selectively Target the CMS2 Subtype of Colorectal Cancer.Cancer Res Commun2023Its Methods give the RRID and name the linePubMed
AMT-562, a Novel HER3-targeting Antibody-Drug Conjugate, Demonstrates a Potential to Broaden Therapeutic Opportunities for HER3-expressing Tumors.Mol Cancer Ther2023Its Methods give the RRID and name the linePubMed
Targeting BRD3 eradicates nuclear TYRO3-induced colorectal cancer metastasis.Sci Adv2023Its Methods give the RRID and name the linePubMed
The Tankyrase Inhibitor OM-153 Demonstrates Antitumor Efficacy and a Therapeutic Window in Mouse Models.Cancer Res Commun2022Its Methods give the RRID and name the linePubMed

1 to 10 of 33

See all 33 papers

Relatives13

RelationCell lineAccessionProblemSource
ParentCOLO 320CVCL_1989Cell lines
Derived from itCOLO 320DM#3CVCL_A6UJCell lines
Derived from itCOLO 320DM#3 SIRT1 KO cl.1CVCL_A6UKCell lines
Derived from itCOLO 320DM#3 SIRT1 KO cl.2CVCL_A6ULCell lines
Derived from itCOLO 320DM#3 SIRT1 KO cl.3CVCL_A6UMCell lines
Derived from itCOLO 320DM#3 SIRT1 KO cl.4CVCL_A6UNCell lines
Derived from itCOLO 320DM#3 SIRT1 KO cl.5CVCL_A6UPCell lines
Derived from itCOLO 320DM#3 SIRT1 KO cl.6CVCL_A6UQCell lines
Derived from itCOLO 320DM-EGFPCVCL_XD07Cell lines
Derived from itCOLO 320DM-RFPCVCL_XD08Cell lines

Cell banks8

Cell bankCatalog numberStatusSource
ATCCCCL-220ATCC
BCRC60108BCRC
CCTCCGDC0042Cellosaurus
CLS300153CLS
ECACC87061205ECACC
JCRBJCRB0225JCRB
KCBKCB 200694YJCellosaurus
KCLB10220KCLB

Data dates

The date of each source this release read.

Cellosaurus
2026-10-22
Cellosaurus
PubMed Central's articles
2026-11-12
PubMed Central's articles
Our copy of PubMed
2026-11-06
Our copy of PubMed

Sources 4

  • CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
  • PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
  • NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
  • PubMedNLM's terms
Each source's terms
  • CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
  • PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
  • NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
  • PubMedNLM's terms

Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.

For software

Read this cell line from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/cell-lines/v1/CVCL_0219

GET https://conductscience.org/api/cell-lines/v1/CVCL_0219/papers?page=2